Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Pomdoctor Limited (POM)

1.5650 +0.0150 (+0.97%)
As of 11:39:00 AM EST. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
410,445.3720 399,914.9640 342,557.9200 304,852.9710 245,216.7160
Cost of Revenue
-361,207.1350 -347,632.8530 -294,863.8670 -266,131.2020 -190,355.4210
Gross Profit
49,238.2370 52,282.1110 47,694.0530 38,721.7690 54,861.2950
Selling, General and Administrative Expenses
-269,564.0680 -155,943.7580 -68,244.7680 -55,992.6990 -54,867.6760
Research and Development Expenses
-117,658.3470 -12,864.6560 -3,002.0400 -3,370.9450 -3,587.8980
Other Income/Expense, Operating
81.2180 152.5990 189.5000 321.5730 280.1570
Operating Income/Expenses
-387,141.1970 -168,655.8150 -71,057.3080 -59,042.0710 -58,175.4170
Total Operating Profit/Loss
-337,902.9600 -116,373.7040 -23,363.2550 -20,320.3020 -3,314.1220
Total Net Finance Income/Expense
-12,535.3160 -12,885.1220 -12,964.5840 -13,849.1190 -16,023.3650
Irregular Income/Expenses
-523.7380 -2,108.5170 -2,238.5250 -1,607.0270 0
Other Income/Expense, Non-Operating
1,812.9030 435.7970 1,200.9300 -1,172.9730 -494.5410
Non-Operating Income/Expenses, Total
-11,246.1510 -14,557.8420 -14,002.1790 -16,629.1190 -16,517.9060
Pretax Income
-349,149.1110 -130,931.5460 -37,365.4340 -36,949.4210 -19,832.0280
Provision for Income Tax
-67.5060 -0.3750 0 0 0
Net Income from Continuing Operations
-349,216.6170 -130,931.9210 -37,365.4340 -36,949.4210 -19,832.0280
Other Net of Taxes Adjustments
-29,242.9810 -81,648.7160 -105,969.6140 -108,440.3540 -105,680.0790
Net Income after Extraordinary Items and Discontinued Operations
-378,459.5980 -212,580.6370 -143,335.0480 -145,389.7750 -125,512.1070
Non-Controlling/Minority Interests
8,385.1590 1.5200 -25.8780 -1.0570 1.8790
Net Income after Non-Controlling/Minority Interests
-370,074.4390 -212,579.1170 -143,360.9260 -145,390.8320 -125,510.2280
Net Income Available to Common Stockholders
-370,074.4390 -212,579.1170 -143,360.9260 -145,390.8320 -125,510.2280
Diluted Net Income Available to Common Stockholders
-370,074.4390 -212,579.1170 -143,360.9260 -145,390.8320 -125,510.2280
Basic EPS
-282.08 -219.60 -72.62 -62.71 -54.14
Diluted EPS
-282.08 -219.60 -72.62 -62.71 -54.14
Basic Weighted Average Shares Outstanding
968.0620 968.0620 1,974.0760 2,318.2960 2,318.2960
Diluted Weighted Average Shares Outstanding
968.0620 968.0620 2,318.2960 2,318.2960 2,318.2960
Income Statement, Supplemental
EBIT
-336,613.7950 -118,046.4240 -24,400.8500 -23,100.3020 -3,808.6630
EBITDA
-336,405.1000 -117,897.1170 -24,266.3400 -22,988.2100 -3,808.6630
Normalized EBITDA
-103,755.8240 -99,364.9170 -22,031.7080 -21,381.1830 -3,808.6630
Normalized Income
-116,567.3410 -112,399.7210 -35,130.8020 -35,342.3940 -19,832.0280
12/31/2022 - 10/8/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: